Wang et al., 2020 - Google Patents
An enzyme-responsive and photoactivatable carbon-monoxide releasing molecule for bacterial infection theranosticsWang et al., 2020
- Document ID
- 12378234138267821190
- Author
- Wang X
- Chen X
- Song L
- Zhou R
- Luan S
- Publication year
- Publication venue
- Journal of Materials Chemistry B
External Links
Snippet
Infections caused by pathogenic bacteria, especially the drug-resistant bacteria, are posing a devastating threat to public health, which underscores the urgent needs for advanced strategies to effectively prevent and treat these intractable issues. Here we report a feasible …
- 206010060945 Bacterial infection 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | An enzyme-responsive and photoactivatable carbon-monoxide releasing molecule for bacterial infection theranostics | |
Lee et al. | Ultrafast discrimination of Gram-positive bacteria and highly efficient photodynamic antibacterial therapy using near-infrared photosensitizer with aggregation-induced emission characteristics | |
Bai et al. | AIEgens for microbial detection and antimicrobial therapy | |
He et al. | In situ green synthesis and characterization of sericin-silver nanoparticle composite with effective antibacterial activity and good biocompatibility | |
Bankoti et al. | Onion derived carbon nanodots for live cell imaging and accelerated skin wound healing | |
Yan et al. | Lasting tracking and rapid discrimination of live gram-positive bacteria by peptidoglycan-targeting carbon quantum dots | |
Sayed et al. | Naphthalimide-based multifunctional AIEgens: Selective, fast, and wash-free fluorescence tracking and identification of Gram-positive bacteria | |
Yu et al. | Carbon dots derived from folic acid as an ultra-succinct smart antimicrobial nanosystem for selective killing of S. aureus and biofilm eradication | |
Wang et al. | Antibody-conjugated liposomes loaded with indocyanine green for oral targeted photoacoustic imaging-guided sonodynamic therapy of Helicobacter pylori infection | |
Du et al. | Enzyme-responsive turn-on nanoprobes for in situ fluorescence imaging and localized photothermal treatment of multidrug-resistant bacterial infections | |
Pebdeni et al. | Smart fluorescence aptasensor using nanofiber functionalized with carbon quantum dot for specific detection of pathogenic bacteria in the wound | |
WO2018210334A1 (en) | Aiegens for cancer cells and gram-positive bacteria discrimination and killing | |
Aw et al. | Enzyme-responsive reporter molecules for selective localization and fluorescence imaging of pathogenic biofilms | |
Severyukhina et al. | Photosensitizer-loaded electrospun chitosan-based scaffolds for photodynamic therapy and tissue engineering | |
Qi et al. | Tetrahedral framework nucleic acids/hyaluronic acid-methacrylic anhydride hybrid hydrogel with antimicrobial and anti-inflammatory properties for infected wound healing | |
Brancato et al. | 3D tumor microtissues as an in vitro testing platform for microenvironmentally-triggered drug delivery systems | |
CN110982513B (en) | Preparation method of fluorescent carbon dots and application of fluorescent carbon dots in cell imaging | |
Serda et al. | Development of photoactive Sweet-C60 for pancreatic cancer stellate cell therapy | |
Wang et al. | Fluorescence ratiometric assay strategy for chemical transmitter of living cells using H2O2-sensitive conjugated polymers | |
Wang et al. | Peroxidase‐mimetic copper‐doped carbon‐dots for oxidative stress‐mediated broad‐spectrum and efficient antibacterial activity | |
Liu et al. | Fluorescent carbon dots with a high nitric oxide payload for effective antibacterial activity and bacterial imaging | |
Xu et al. | Photoactive silver nanoagents for backgroundless monitoring and precision killing of multidrug-resistant bacteria | |
Lin et al. | Amphiphilic alginate-based fluorescent polymer nanoparticles: Fabrication and multifunctional applications | |
Luo et al. | Near-infrared fluorescence probe for indication of the pathological stages of wound healing process and its clinical application | |
Singh et al. | Peptide nanostructure-mediated antibiotic delivery by exploiting H2S-rich environment in clinically relevant bacterial cultures |